Media contacts:
Holly Korschun, 404-727-3990,
Nancy Seideman, 404-727-0640,

October 22, 2003


Emory University Continues Rapid Growth In Research Funding In 2003

Emory University continued its rapid trajectory of research growth in the 2003 fiscal year, receiving a total of $319.1 million in sponsored research funding. This represents an increase of $38 million, or 14 percent, over research funding in FY02. During the past five years sponsored research funding at Emory has grown by more than 93 percent, making it one of the fastest growing research universities in the nation. Federal funding was responsible for more than 75 percent of the FY03 total, with funding from the National Institutes of Health (NIH) making up 61 percent of the total.

The Woodruff Health Sciences Center received $295.5 million, more than 92 percent of the university total and a greater than 16 percent increase over FY02 funding. According to the Office of Sponsored Programs, research funding in the Rollins School of Public Health ($45.1 million) grew by 24 percent in FY03, funding in the School of Medicine ($204 million) grew by 17 percent, and funding in the Nell Hodgson Woodruff School of Nursing ($3.3 million) grew by 26 percent. Research funding for Yerkes National Primate Research Center was $43 million, an increase of 5 percent. Federal money was responsible for 76 percent of Health Sciences Center funding, with money from the NIH making up 65 percent of the total.

"It is a significant and notable fact that Emory scientists have won these research funds competitively, on a national basis, even within these difficult fiscal times," says Frank Stout, vice president for research at Emory. "These are dollars that have been brought into Georgia through the intellectual capability of our faculty, and these funds will provide additional support for the state's economy."

The top 10 departments within the university for funded research in FY03 were the departments of medicine, neurology, psychiatry, behavioral sciences and health education, pathology and laboratory medicine, surgery, pediatrics, epidemiology, Yerkes National Primate Research Center division of administration, and Yerkes Department of Microbiology and Immunology.

Collaborative research with other universities and interdisciplinary research within the university were hallmarks of the year's funding. Research in vaccines, immunology, emerging infections and biodefense garnered substantial research dollars, including continuing development of HIV/AIDS vaccines within Yerkes National Primate Research Center, the Emory Vaccine Center, and the microbiology and immunology department in the School of Medicine. Following years of federally funded research, an HIV vaccine developed at Emory and the NIH entered human clinical trials early in 2003.

Emory received funding this year from the National Institute of Allergy and Infectious Diseases as a member of four new research consortia: a Regional Center of Excellence for Emerging Infections and Biodefense led by Duke University; an Emory-led Cooperative Center for Translational Research on Human Immunology and Biodefense; a consortium led by the University of Alabama-Birmingham to develop a new class of HIV vaccines; and a collaborative project led by Novavax Inc. to develop HIV vaccines.

Emory's Winship Cancer Institute was awarded nearly $2 million through a National Cancer Institute (NCI) Planning Grant--a critical first step in attaining designation as an NCI Comprehensive Cancer Center. Winship also received a $10 million grant from the U.S. Department of Defense Prostate Cancer Research Program to develop a consortium of 13 universities working to identify entirely new therapeutic targets and concepts for effective treatment of advanced prostate cancer.

The NIH awarded the Emory Center for AIDS Research (CFAR) more than $7.3 million in a renewal of its CFAR status.

Lung disease research received substantial funding in FY03, with $10 million from the NIH for two separate projects, one studying the effects of alcohol abuse on lung disease, and a multi-institutional investigation aimed at improving lung cancer detection in smokers. Researchers at the School of Public Health received $3 million from the Robert Wood Johnson Foundation as part of funding for the Tobacco Technical Assistance Consortium to assist states and communities in reducing tobacco use. R

esearch funding in Emory College was $16.8 million in FY03. The Center for Fundamental and Applied Molecular Evolution (FAME), a joint initiative with the Georgia Institute of Technology housed at Emory, received $600,000 in funding, partly from the National Science Foundation. FAME scientists study evolutionary principles and their application to the synthesis of novel molecules and materials. The interdisciplinary center focuses on fundamental questions at the interface between chemistry, biology and physics.

A sampling of numerous other funded projects includes: $2.2 million to the Candler School of Theology for its Youth Theological Initiative; $5 million for a School of Medicine collaboration with the Medical University of South Carolina and community clinicians for a Specialized Center of Research on Sex and Gender Factors Affecting Women's Health; $1.5 million to the School of Public Health for an Interfaith Health Program designed to promote community health in seven states; $5 million from the Helene Fuld Health Trust to the nursing school for endowment support of an innovative program to increase the nation's supply of university-trained nurse leaders; and $2.6 million for an interdisciplinary Digestive Diseases Research Center in the School of Medicine.

Return to October Index

Press Release Archives Page

For more general information on The Robert W. Woodruff Health Sciences Center
call Health Sciences Communication's Office at 404-727-5686,
or send e-mail to


Copyright © Emory University, 2001. All Rights Reserved.